News Update

Mar 01, 2002
Pharmaceutical Executive
t a January meeting in Geneva, the Global Fund to fight AIDS, Tuberculosis, and Malaria (GFATM)-set up last year by an alliance of private donors, nongovernmental organizations (NGOs), foundations, national governments, and intergovernmental organizations-elected its directors, announced its funding criteria, and approved its first call for funding proposals.
Mar 01, 2002
Pharmaceutical Executive
Washington DC-As part of its continuing investigation into competition and intellectual property rights, the US Federal Trade Commission and the Antitrust Division of the Department of Justice recently kicked off a series of hearings.
Mar 01, 2002
Pharmaceutical Executive
Pfizer's $20 million donation of the long-acting antibiotic Zithromax (azithromycin), which is effective against trachoma with a single annual oral dose, has propelled the worldwide effort against the disease into its second phase
Mar 01, 2002
Pharmaceutical Executive
GSK in Hot Water
Feb 01, 2002
Pharmaceutical Executive
Washington, DC-A new advisory committee appointed by HHS secretary Tommy Thompson will scrutinize agency policies to identify ways to improve programs and regulations.
Feb 01, 2002
Pharmaceutical Executive
Geneva-The pharma industry has given a guarded welcome to a World Health Organization report that explicitly links poverty and poor health.
Feb 01, 2002
Pharmaceutical Executive
Washington DC-Abbott Labs and Bayer made Multinational Monitor's 2001 list of the ten worst corporations. The Washington-based magazine was founded by consumer activist and one-time US presidential hopeful Ralph Nader.
Feb 01, 2002
Pharmaceutical Executive
Washington, DC-Pro-life advocates recently dropped a lawsuit challenging the promotion of abortifacient RU-486 through ads sponsored by the National Abortion Federation. The suit charged NAF with using deceptive advertising by promoting Mifepristone as safe in several national magazines, including Self, Cosmopolitan, InStyle, Vanity Fair, and People. The ads stated, "You have the freedom to choose. And now, you have another safe abortion choice."
Feb 01, 2002
Pharmaceutical Executive
In July, after a wide-ranging review of pharmaceutical legislation, the EC determined that the current ban on direct-to- consumer advertising should be balanced by a pilot system aimed to "ensure the availability of better, clear, and reliable information on authorized pharmaceuticals." It said the pilot should apply to diabetes, AIDS, and asthma products, citing the strong public demand for such information and the ease of monitoring the results of a five-year pilot study for those products.
Jan 01, 2002
Pharmaceutical Executive
Once thought to be a disease of the past, tuberculosis is now a front burner health problem.
native1_300x100
lorem ipsum